|
End-of-day quote
Pakistan S.E.
2026-09-25
|
5-day change | 1st Jan Change | ||
| 314.37 PKR | -0.39% |
|
-2.06% | -19.35% |
Stock exchange
Pakistan S.E.
GLAXO 314.37 ₨
-0.39%
27.58M
₨
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
| GLAXO | 314.37PKR | -0.39% | 27.58M ₨ |
Quotes 5-day view: GlaxoSmithKline Pakistan Limited
End-of-day quote Pakistan S.E.| 2026-09-21 | 2026-09-22 | 2026-09-23 | 2026-09-24 | 2026-09-25 | |
|---|---|---|---|---|---|
| Last | PKR 322.61 | PKR 322.57 | PKR 321.36 | PKR 315.59 | PKR 314.37 |
| Volume | 100,137 | 71,084 | 122,302 | 118,541 | 87,742 |
| Change | +0.50% | -0.01% | -0.38% | -1.80% | -0.39% |
| Opening | PKR 321.00 | PKR 321.00 | PKR 323.00 | PKR 323.00 | PKR 315.59 |
| High | PKR 323.00 | PKR 324.00 | PKR 326.05 | PKR 323.00 | PKR 317.00 |
| Low | PKR 317.55 | PKR 319.10 | PKR 320.55 | PKR 314.00 | PKR 312.00 |
Performance
| 1 day | -0.39% | ||
| 1 week | -2.06% | ||
| Current month | -6.15% | ||
| 1 month | -8.46% | ||
| 3 months | -14.31% | ||
| 6 months | -1.78% | ||
| Current year | -19.35% | ||
| 1 year | -30.32% | ||
| 3 years | +335.60% | ||
| 5 years | +112.41% | ||
| 10 years | +46.73% |
Volumes
marketsDaily volume
87,742
Avg. Volume 20 sessions
179,276
Avg. Volume 20 sessions PKR
56,358,996.12
Avg. Volume 20 sessions USD
203,455.98
Record volume 1
13,104,330
Record volume 2
4,738,800
Record volume 3
4,652,400
Capital turnover ratio
0
Float rotation
0
Basic data
Market Cap (PKR)
100,116,558,178
Market Cap (USD)
361,457,716
Net sales (PKR)
65,900,901,000
Net sales (USD)
237,926,569
Number of employees
1,606
Sales / Employee (PKR)
41,034,185
Sales / Employee (USD)
148,149
Free-Float
16.89%
Free-Float capitalization (PKR)
16,906,441,040
Free-Float capitalization (USD)
61,038,490
Average Daily Capital Traded
0.06%
Indicators
Moving average 5 days
319.3
Moving average 20 days
317.35
Moving average 50 days
335.55
Moving average 100 days
346.75
Price spread / (MMA5)
+1.57%
Price spread / (MMA20)
+0.95%
Price spread / (MMA50)
+6.74%
Price spread / (MMA100)
+10.30%
RSI 9 days
40.93
RSI 14 days
39.31
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.39% | -2.06% | -30.32% | +335.60% | 361M | ||
| +0.13% | +2.65% | +63.34% | +115.27% | 1,055B | ||
| +0.20% | +0.46% | +50.92% | +72.63% | 654B | ||
| -0.29% | +0.14% | +19.82% | +72.62% | 467B | ||
| -0.85% | +0.98% | +42.13% | +42.98% | 348B | ||
| +0.71% | +4.08% | +21.75% | +29.57% | 275B | ||
| +1.23% | +0.42% | +14.11% | +12.90% | 258B | ||
| +2.11% | +7.51% | +51.88% | +54.14% | 224B | ||
| +0.83% | +0.55% | +34.64% | +99.77% | 187B | ||
| 0.00% | -10.14% | -27.40% | -60.93% | 171B | ||
| Average | +0.37% | +0.41% | +24.09% | +77.46% | 363.87B | |
| Weighted average by Cap. | +0.27% | +1.32% | +40.42% | +68.69% |
Historical Quotes: GlaxoSmithKline Pakistan Limited
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Price Extremes
| 1 week | 312 | 326.05 | |
| 1 month | 299.8 | 341.99 | |
| Current year | 293.09 | 459.27 | |
| 1 year | 293.09 | 459.27 | |
| 3 years | 71.55 | 481 | |
| 5 years | 68 | 481 | |
| 10 years | 68 | 481 |
Monthly variations
Annual variations
| 2026 | -19.35% | ||
| 2025 | -1.80% | ||
| 2024 | +378.26% | ||
| 2023 | -5.45% | ||
| 2022 | -35.70% | ||
| 2021 | -28.84% | ||
| 2020 | +19.47% | ||
| 2019 | +42.50% | ||
| 2018 | -32.88% | ||
| 2017 | -27.64% | ||
| 2016 | +5.44% | ||
| 2015 | +0.32% | ||
| 2014 | +77.11% | ||
| 2013 | +104.32% | ||
| 2012 | +20.25% | ||
| 2011 | -12.53% | ||
| 2010 | -19.29% | ||
| 2009 | +43.89% | ||
| 2008 | -60.53% | ||
| 2007 | +52.36% | ||
| 2006 | +5.94% | ||
| 2005 | +28.63% | ||
| 2004 | -5.26% | ||
| 2003 | +225.19% | ||
| 2002 | +12.80% | ||
| 2001 | -16.20% | ||
| 2000 | +70.48% | ||
| 1999 | +16.67% | ||
| 1998 | -15.09% | ||
| 1997 | -26.39% | ||
| 1996 | -41.94% | ||
| 1995 | -27.06% | ||
| 1994 | -10.29% | ||
| 1993 | +43.56% | ||
| 1992 | +1.93% |
- Stock Market
- Stocks
- GLAXO Stock
- Quotes GlaxoSmithKline Pakistan Limited
Select your edition
All financial news and data tailored to specific country editions
















